On the toxicity of ibogaine
Clinical Toxicology May 31, 2016 DOI: 10.1080/15563650.2016.1190017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Ibogaine |
| Citations | 3 |
| Key points | Argues that a review of ibogaine omitted discussion of its cardiac risks and a defined therapeutic dose. |
Abstract
We appreciate Litjens’ review on ibogaine,[1] and an opportunity to comment on some noteworthy gaps that may be of interest to the readers.It is curious that neither a “therapeutic” dose, frequentl...